155 related articles for article (PubMed ID: 7900630)
1. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and action of urodilatin infusion in healthy volunteers.
Carstens J; Jensen KT; Pedersen EB
Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
[TBL] [Abstract][Full Text] [Related]
3. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure.
Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1992 Oct; 22(10):662-9. PubMed ID: 1333960
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
6. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
7. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
Franco-Saenz R; Somani P; Mulrow PJ
Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
[TBL] [Abstract][Full Text] [Related]
8. Postprandial natriuresis in humans: further evidence that urodilatin, not ANP, modulates sodium excretion.
Drummer C; Franck W; Heer M; Forssmann WG; Gerzer R; Goetz K
Am J Physiol; 1996 Feb; 270(2 Pt 2):F301-10. PubMed ID: 8779891
[TBL] [Abstract][Full Text] [Related]
9. Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
Carstens J; Grønbaek H; Larsen HK; Pedersen EB; Vilstrup H
BMC Gastroenterol; 2007 Jan; 7():1. PubMed ID: 17257428
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
Carstens J; Pedersen EB
Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
[TBL] [Abstract][Full Text] [Related]
11. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
[TBL] [Abstract][Full Text] [Related]
12. [Effects of dopamine infusion on the release of atrial natriuretic factor].
Fontana F; Ruffini M; Capelli M; Bernardi P
G Ital Cardiol; 1990 Mar; 20(3):227-35. PubMed ID: 2140554
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
[TBL] [Abstract][Full Text] [Related]
14. Urodilatin: a better natriuretic peptide?
Vesely DL
Curr Heart Fail Rep; 2007 Sep; 4(3):147-52. PubMed ID: 17883990
[TBL] [Abstract][Full Text] [Related]
15. Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure.
Kentsch M; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1995 Apr; 25(4):281-3. PubMed ID: 7601204
[TBL] [Abstract][Full Text] [Related]
16. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.
Brenner P; Meyer M; Reichenspurner H; Meiser B; Müller R; Mentz P; Schulz-Knappe P; Uberbacher HJ; Kreuzer E; Uberführ P
Eur J Med Res; 1995 Dec; 1(3):137-43. PubMed ID: 9389675
[TBL] [Abstract][Full Text] [Related]
17. Effect of water temperature on diuresis-natriuresis: AVP, ANP, and urodilatin during immersion in men.
Nakamitsu S; Sagawa S; Miki K; Wada F; Nagaya K; Keil LC; Drummer C; Gerzer R; Greenleaf JE; Hong SK
J Appl Physiol (1985); 1994 Oct; 77(4):1919-25. PubMed ID: 7836219
[TBL] [Abstract][Full Text] [Related]
18. Renal and systemic effects of urodilatin in rats with high-output heart failure.
Abassi ZA; Powell JR; Golomb E; Keiser HR
Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
Bestle MH; Bie P
Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
